Sunday, June 4, 2023

BioNxt receives approval for European study of rotigotine transdermal patch for Parkinson’s

The company has completed manufacturing of all transdermal clinical samples used in the study based on TDS platform technology developed by the German subsidiary of BioNXT.

Nation World News Desk
Nation World News Desk
Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.
Latest news
Related news


Please enter your comment!
Please enter your name here